Skip to content

ENTAENANTA PHARMACEUTICALS INC

CUSIP 29251M106 · common stock

1 tracked investor held ENANTA PHARMACEUTICALS INC (ENTA) at the end of Q3 2026, worth $22.8M. The largest holder was Adar1 Capital Management, with 1.0% of its portfolio.

Holders · Q3 2026
1
New holders
0
Value held
$22.8M
Quarter-end price (est.)
$13.18

Investors holding ENTA · Q3 2026

InvestorWeightSharesValueChange
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.97%1,733,320$22.8MADD+28.9%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026100$22.8M$13.18
Q2 2026100$19.6M$14.58
Q1 2026100$648.6K$12.63
Q4 2025100$652.2K$15.77